相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells
G. O'Callaghan et al.
BRITISH JOURNAL OF CANCER (2008)
Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway
Ichiro Fujiwara et al.
DISEASES OF THE COLON & RECTUM (2008)
Urinary leukotriene E-4 excretion: A biomarker of inflammatory bowel disease activity
Francoise Stanke-Labesque et al.
INFLAMMATORY BOWEL DISEASES (2008)
Prostaglandin E-2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells
Hiroshi Shiraishi et al.
INTERNATIONAL IMMUNOLOGY (2008)
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors
Masayuki Fukata et al.
GASTROENTEROLOGY (2007)
EGFR signaling is required for TGF-β1-Mediated COX-2 induction in human bronchial epithelial cells
Ming Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS) - Induced colon lesions in rats
Mitsuaki Okayama et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis
Karin Mueller-Decker et al.
MOLECULAR CARCINOGENESIS (2007)
Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury
Sarah L. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration
Guang-Liang Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and Tumor Necrosis Factor-alpha converting enzyme
Mazin A. Al-Salihi et al.
CELLULAR SIGNALLING (2007)
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine
Masayuki Fukata et al.
GASTROENTEROLOGY (2006)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2
Mitsuhiro Okano et al.
IMMUNOLOGY (2006)
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer
VR Holla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study
WJ Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention
M Mutoh et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The initiation of colon cancer in a chronic inflammatory setting
R Chen et al.
CARCINOGENESIS (2005)
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner
K Krysan et al.
CANCER RESEARCH (2005)
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis
M Fukata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
15d-PGJ2:: The anti-inflammatory prostaglandin?
JU Scher et al.
CLINICAL IMMUNOLOGY (2005)
Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury
SL Pull et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effects of prostaglandin E1 and E2 analogues on mucosal injury-induced, and on bacterial translocation promoted by, experimental intestinal obstruction
G Gurleyik et al.
JOURNAL OF INVESTIGATIVE SURGERY (2004)
Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ
DZ Wang et al.
CANCER CELL (2004)
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
Y Shoji et al.
GUT (2004)
Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor
FG Buchanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Enhancement of colon carcinogenesis by prostaglandin E2 administration
T Kawamori et al.
CARCINOGENESIS (2003)
Prostaglandin biology in inflammatory bowel disease
JL Wallace
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2001)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Estimation of mucosal inflammatory mediators in rat DSS-induced colitis - Possible role of PGE(2) in protection against mucosal damage
I Hirata et al.
DIGESTION (2001)
Prostaglandin E2 upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages
B Hinz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation
HS Cooper et al.
CARCINOGENESIS (2000)